HSF1 and triple-negative breast carcinoma: HSF1 was identified to be more active in basal or triple-negative breast cancers (10), which have striking molecular similarities to HGSOC, and HSF1 was recently shown to be overexpressed and/or hyperactivated in HGSOC and other solid tumors (11–14).